Key result
Transcatheter aortic valve replacement (TAVR), developed over 2 decades, is discussed alongside lessons from nearly 5 decades of percutaneous coronary intervention (PCI).
Answers are grounded in this paper and cite their sources.
This commentary highlights the evolution of transcatheter aortic valve replacement (TAVR) and the need to consider future redo TAVR procedures during the initial valve implantation.
The first transcatheter aortic valve replacement (TAVR) was performed more than 2 decades ago; TAVR is now utilized as a definitive therapy for patients with severe aortic valve stenosis across the full spectrum of surgical risk [1,2]. There are lessons to be learned from nearly 5 decades of percutaneous coronary intervention (PCI), during which successive innovations have addressed the limitations of earlier treatments.
No takes yet. Share an insight, caveat, or question.
Potluri et al. (2026) conducted an editorial in Severe aortic valve stenosis. Redo transcatheter aortic valve replacement (TAVR) was evaluated. Transcatheter aortic valve replacement (TAVR), developed over 2 decades, is discussed alongside lessons from nearly 5 decades of percutaneous coronary intervention (PCI).
Synapse has enriched 10 related papers. Consider them for comparative context: